These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9251123)

  • 1. New evidence that NSAIDs reduce breast cancer risk.
    Oncology (Williston Park); 1997 Jul; 11(7):1046. PubMed ID: 9251123
    [No Abstract]   [Full Text] [Related]  

  • 2. [What's in the future? New NSAIDs].
    Laufer S
    Pharm Unserer Zeit; 2002; 31(2):164-9. PubMed ID: 11977452
    [No Abstract]   [Full Text] [Related]  

  • 3. New NSAIDs--inhibitors of cyclooxygenase 2--and renal damage.
    Navarro JF; Mora C; García J
    Br J Rheumatol; 1996 Dec; 35(12):1332. PubMed ID: 9010074
    [No Abstract]   [Full Text] [Related]  

  • 4. The molecular perspective: cyclooxygenase-2.
    Goodsell DS
    Stem Cells; 2000; 18(3):227-9. PubMed ID: 10840077
    [No Abstract]   [Full Text] [Related]  

  • 5. COX provides missing link in mechanism of aspirin in colon cancer.
    Wunsch H
    Lancet; 1998 Jun; 351(9119):1864. PubMed ID: 9652680
    [No Abstract]   [Full Text] [Related]  

  • 6. Non steroidal anti-inflammatory drugs, cyclooxygenase selectivity and gastrointestinal toxicity.
    Jacob M; Simpson R; Bjarnason I
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):12-8. PubMed ID: 9615258
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?].
    Kankaanranta H; Vapaatalo H
    Duodecim; 1996; 112(5):419-24. PubMed ID: 10592604
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective cyclooxygenase-2 inhibition: biological and clinical effects.
    Conti F; Spinelli FR; Ossandon A; Valesini G
    Isr Med Assoc J; 2000 Nov; 2(11):841-7. PubMed ID: 11344755
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
    Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
    Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAIDs to prevent colorectal cancer: a question of sensitivity.
    Elder DJ; Paraskeva C
    Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741
    [No Abstract]   [Full Text] [Related]  

  • 12. New perspectives for nonsteroidal antiinflammatory therapy.
    de Brum-Fernandes AJ
    J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):78-82. PubMed ID: 12905826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correspondence re: Cotterchio et al., Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 10: 1213-1217, 2001.
    Mokbel K; Singh-Ranger G; Kirkpatrick K
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):674; author reply 674. PubMed ID: 12101118
    [No Abstract]   [Full Text] [Related]  

  • 15. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 16. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 17. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever.
    Simmons DL; Wagner D; Westover K
    Clin Infect Dis; 2000 Oct; 31 Suppl 5():S211-8. PubMed ID: 11113025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 20. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
    Wigand R
    Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.